Gilead and PAHO agree to expand access to PrEP against HIV in Latin America

Gilead and PAHO sign an agreement to facilitate access to a key drug for HIV prevention in Latin America and the Caribbean. The initiative seeks to reduce new infections and improve access to preventive treatments, with support from local production in Brazil.